Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci
Open Access
- 1 May 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (5) , 899-900
- https://doi.org/10.1128/aac.34.5.899
Abstract
The activities of teicoplanin and vancomycin against 362 coagulase-negative staphylococci were determined by an agar dilution method. At the 4- and 32-micrograms/ml breakpoint levels of the National Committee for Clinical Laboratory Standards, 23.2% of the strains were intermediate and 1.7% were resistant to teicoplanin, in contrast to less than 0.3% intermediate to vancomycin. Resistant strains belonged to the species Staphylococcus epidermidis (74%) and S. haemolyticus (19%).This publication has 8 references indexed in Scilit:
- Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocciAntimicrobial Agents and Chemotherapy, 1989
- In-vitro teicoplanin-resistance in coagulase-negative staphylococci from patients with endocarditis and from a cardiac surgery unitJournal of Antimicrobial Chemotherapy, 1988
- Microbiological properties of teicoplaninJournal of Antimicrobial Chemotherapy, 1988
- The effect of medium and inoculum on the actirity of vancomycin and teicoplanin against coagulase-negative staphylococciJournal of Antimicrobial Chemotherapy, 1987
- TEICOPLANIN-RESISTANT COAGULASE-NEGATIVE STAPHYLOCOCCIThe Lancet, 1987
- TEICOPLANIN-RESISTANT COAGULASE-NEGATIVE STAPHYLOCOCCUSThe Lancet, 1986
- TEICOPLANIN-RESISTANT COAGULASE-NEGATIVE STAPHYLOCOCCUSThe Lancet, 1986